DUBLIN--(BUSINESS WIRE)--The "Global High-performance Liquid Chromatography (HPLC) Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The high-performance liquid chromatography (HPLC) market will register a CAGR of almost 5% by 2023.
Several private and government stakeholders are investing heavily in R&D activities in the healthcare sector. This is mainly to launch products with innovative new technologies in the field of HPLC and to increase the potential of the healthcare industry.
Pharmaceutical companies are opting for HPLC for sample testing and analysis. This technique is used to identify potential ingredients for manufacturing drugs.
The increasing investments are enabling vendors to develop and manufacture more innovative HPLC products. This is driving the demand among end-users and leading to the rapid growth of the global high-performance liquid chromatography (HPLC) market.
High specificity, sensitivity and accuracy of HPLC
The adoption of HPLC has been increasing in the healthcare sector due to the high specificity, sensitivity, and accuracy of HPLC among other techniques such as GC.
Furthermore, the availability of different types of columns for use during HPLC analysis aids in the successful analysis of analytes in biological fluids. These benefits are driving the adoption of HPLC. This is expected to have a positive impact on the healthcare industry.
High cost of HPLC instruments
The high cost of HPLC instruments is a factor that restricts the market growth. The development of HPLC instruments includes the addition of automation features and data analysis software, which is expensive.
The high cost of these instruments makes them unaffordable for small research laboratories. Therefore, the high cost of HPLC instruments, including systems, detectors, and pumps, hinders the growth of the global high-performance liquid chromatography (HPLC) market.
Competitive Landscape
The market appears to be fairly fragmented with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Key Players
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- Instruments - Market size and forecast 2018-2023
- Consumables - Market size and forecast 2018-2023
- Accessories - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
- Increasing use of HPLC
- Technological advances in HPLC
- Increasing strategic developments by manufacturers
PART 11: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/sbt2hp/global?w=4
